DrugMetabolite, Drug Metabolite, Dehydro Nifedipine, BAY-b 4759, calcium channel
Dehydro Nifedipine (BAY-b 4759) is the primary human plasma metabolite of the calcium channel blocker nifedipine, formed via CYP3A4/5 metabolism. This bioactive metabolite inhibits glucose uptake in PC-12 cells (IC50 = 130 µM), making it a relevant compound for research in metabolic studies and drug interaction mechanisms.